Scarica l'app Stockscreener
48.60
5.37%
-2.76
Dopo l'orario di chiusura:
48.60
Precedente Chiudi:
$51.36
Aprire:
$51.4
Volume 24 ore:
346.41K
Relative Volume:
1.63
Capitalizzazione di mercato:
$456.40M
Reddito:
-
Utile/perdita netta:
$-81.17M
Rapporto P/E:
-4.7955
EPS:
-10.1344
Flusso di cassa netto:
$-82.84M
1 W Prestazione:
+3.98%
1M Prestazione:
+56.07%
6M Prestazione:
+261.07%
1 anno Prestazione:
-36.88%
Intervallo 1D:
$48.37
$55.89
Intervallo di 1 settimana:
$40.70
$55.89
Portata 52W:
$10.29
$85.00
Korro Bio Inc Stock (KRRO) Company Profile
Nome
Korro Bio Inc
Settore
Industria
Telefono
617-468-1999
Indirizzo
60 FIRST STREET, CAMBRIDGE
Confronta KRRO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KRRO
Korro Bio Inc
|
48.60 | 429.92M | 0 | -81.17M | -82.84M | -10.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Korro Bio Inc Stock (KRRO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-04-16 | Iniziato | Chardan Capital Markets | Buy |
| 2025-01-10 | Iniziato | Oppenheimer | Outperform |
| 2024-10-21 | Iniziato | Raymond James | Strong Buy |
| 2024-08-14 | Iniziato | William Blair | Outperform |
| 2024-03-28 | Reiterato | H.C. Wainwright | Buy |
| 2024-02-27 | Iniziato | BMO Capital Markets | Outperform |
| 2023-12-04 | Iniziato | H.C. Wainwright | Buy |
| 2023-11-29 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-11-10 | Iniziato | Piper Sandler | Overweight |
| 2023-02-15 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2023-02-13 | Downgrade | Cowen | Outperform → Market Perform |
| 2021-09-22 | Downgrade | Goldman | Buy → Neutral |
| 2021-01-27 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-12-22 | Iniziato | B. Riley Securities | Buy |
| 2020-07-14 | Iniziato | Oppenheimer | Outperform |
| 2020-05-18 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-10-28 | Iniziato | Cowen | Outperform |
| 2019-10-28 | Iniziato | Goldman | Buy |
| 2019-10-28 | Iniziato | JP Morgan | Overweight |
Mostra tutto
Korro Bio Inc Borsa (KRRO) Ultime notizie
Long term hold vs stop loss in Korro Bio Inc.July 2025 Price Swings & Fast Entry Momentum Trade Alerts - newser.com
Will Korro Bio Inc. stock deliver strong dividend growthTrade Volume Summary & Fast Entry and Exit Trade Plans - newser.com
Is Korro Bio Inc. stock positioned for long term growthWeekly Risk Summary & Precise Buy Zone Tips - newser.com
Risk vs reward if holding onto Korro Bio Inc.July 2025 Macro Moves & Free Reliable Trade Execution Plans - newser.com
Short interest data insights for Korro Bio Inc.M&A Rumor & AI Enhanced Market Trend Forecasts - newser.com
Using Ichimoku Cloud for Korro Bio Inc. technicals2025 Valuation Update & High Conviction Buy Zone Alerts - newser.com
Analyzing recovery setups for Korro Bio Inc. investors2025 Trading Volume Trends & Free Weekly Chart Analysis and Trade Guides - newser.com
Using Python tools to backtest Korro Bio Inc. strategies2025 Top Gainers & Fast Moving Stock Trade Plans - newser.com
Tools to assess Korro Bio Inc.’s risk profileWeekly Profit Analysis & Stock Portfolio Risk Management - newser.com
Using economic indicators to assess Korro Bio Inc. potential2025 Valuation Update & Fast Exit Strategy with Risk Control - newser.com
Live market analysis of Korro Bio Inc.July 2025 Setups & Detailed Earnings Play Alerts - newser.com
Key metrics from Korro Bio Inc.’s quarterly dataJuly 2025 Momentum & Stepwise Entry/Exit Trade Alerts - newser.com
Has Korro Bio Inc. formed a bullish divergence2025 Earnings Impact & Community Verified Swing Trade Signals - newser.com
Korro Bio CFO Vineet Agarwal Resigns, Interim Appointed - The Globe and Mail
Is a relief rally coming for Korro Bio Inc. holdersEarnings Growth Summary & Short-Term High Return Strategies - newser.com
Korro Bio, Inc. Announces Chief Financial Officer Changes, Effective October 17, 2025 - MarketScreener
Korro Bio CFO Vineet Agarwal to step down, CEO Ram Aiyar named interim CFO - Investing.com Canada
Korro BioVineet Agarwal announces intention to resign from his position of CFO - MarketScreener
What analysts say about Korro Bio Inc stockEarnings Growth Patterns & Free Double Digit Growth Tips - earlytimes.in
What drives Korro Bio Inc stock priceValue Traps to Avoid & Free High Yield Investment Strategies - earlytimes.in
Chart based analysis of Korro Bio Inc. trends2025 Bull vs Bear & Real-Time Volume Analysis - newser.com
Is Korro Bio Inc. stock reversal real or fake2025 Year in Review & Momentum Based Trading Ideas - newser.com
Korro Bio Inc. stock prediction for this weekWeekly Stock Analysis & Free Community Supported Trade Ideas - newser.com
When is the best time to exit Korro Bio Inc.Day Trade & AI Forecasted Entry/Exit Points - newser.com
Press Release: Korro Reports Full Year 2024 Financial Results and Provides Business Updates - 富途牛牛
Piper Sandler Maintains Korro Bio(KRRO.US) With Buy Rating, Maintains Target Price $180 - 富途牛牛
Applying sector rotation models to Korro Bio Inc.Market Growth Report & Safe Capital Growth Tips - newser.com
How to build a custom watchlist for Korro Bio Inc.2025 Investor Takeaways & Community Consensus Picks - newser.com
Korro Bio Inc Azioni (KRRO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Korro Bio Inc Azioni (KRRO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Agarwal Vineet | Chief Financial Officer |
Nov 11 '24 |
Sale |
70.00 |
800 |
56,000 |
0 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):